Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update

被引：0
|
作者：
Mooney, Kelly [1 ]
Stehr, Henning [1 ]
Kunder, Christian [2 ]
Zehnder, James [2 ]
Allison, Kimberly [2 ]
Lin, Chieh-Yu [3 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Washington Univ, Sch Med, St Louis, MO USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
216
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Accurate Assessment of HER2 Gene Status for Invasive Component of Breast Cancer by Combination of Immunohistochemistry and Chromogenic In Situ Hybridization
    聂秀
    贺骏
    李燕
    潘丹珍
    潘华雄
    翁密霞
    杨秀萍
    刘春萍
    黄韬
    Current Medical Science, 2013, (03) : 379 - 384
  • [42] Detection of ERBB2 Amplification in Breast Carcinoma by Next-Generation Sequencing: A Comparative Study with Immunohistochemistry and Fluorescence in Situ Hybridization
    Ross, D. S.
    Zehir, A.
    Cheng, D. T.
    Ladanyi, M.
    Arcila, M. E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 760 - 760
  • [43] Evaluation of HER-2/neu gene status in breast cancer by chromogenic in situ hybridization: Comparison with immunohistochemistry
    Kounelis, S
    Kapranos, N
    Malamos, N
    Kokka, E
    Arvanitis, H
    Kouri, E
    LABORATORY INVESTIGATION, 2003, 83 (01) : 37A - 37A
  • [44] Evaluation of HER-2/neu gene status in breast cancer by chromogenic in situ hybridization: Comparison with immunohistochemistry
    Kounelis, S
    Kapranos, N
    Malamos, N
    Kokka, E
    Arvanitis, H
    Kouri, E
    MODERN PATHOLOGY, 2003, 16 (01) : 37A - 37A
  • [45] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Sui, Weiguo
    Ou, Minglin
    Chen, Jiejing
    Wan, Youhua
    Peng, Hongbo
    Qi, Minfang
    Huang, He
    Dai, Yong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7 : 83
  • [46] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Weiguo Sui
    Minglin Ou
    Jiejing Chen
    Youhua Wan
    Hongbo Peng
    Minfang Qi
    He Huang
    Yong Dai
    World Journal of Surgical Oncology, 7
  • [47] Comparison between silver and flourescence in situ hybridization for detecting HER2 gene status in breast cancer
    De La Cruz Mera, A.
    De La Cruz Davila, A.
    VIRCHOWS ARCHIV, 2009, 455 : 96 - 97
  • [48] Utility of HER2 Immunohistochemistry in Clarifying HER2 Status in Breast Cancer with HER2:CEP17 Ratio <2 and Average >/=4.0 and <6.0 HER2 Signals per Tumor Cell by Fluorescence in-situ Hybridization (Focused Update Group 4)
    Muller, Kristen
    Marotti, Jonathan
    Tafe, Laura
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 223 - 223
  • [49] Utility of HER2 Immunohistochemistry in Clarifying HER2 Status in Breast Cancer with HER2:CEP17 Ratio <2 and Average >/=4.0 and <6.0 HER2 Signals per Tumor Cell by Fluorescence in-situ Hybridization (Focused Update Group 4)
    Muller, Kristen
    Marotti, Jonathan
    Tafe, Laura
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 223 - 223
  • [50] The spectrum of HER2 expression in breast cancer: linking immunohistochemistry quantification with in situ hybridization assay
    António Polónia
    Carolina Canelas
    Ana Caramelo
    Virchows Archiv, 2022, 480 : 1171 - 1179
12345